$5.5 Million Awarded to Transvaginal Mesh Victim

Share Article

Ennis & Ennis, P.A. explains the groundbreaking verdict of the first transvaginal mesh lawsuit to go to trial

This verdict gives validity and merit to women’s transvaginal mesh claims and illustrates the gravity of some of the injuries sustained

A jury awarded a woman $5.5 million against C.R. Bard for serious injuries sustained by a transvaginal mesh device. This was the first transvaginal mesh claim to go to trial, however there are currently hundreds of other similar cases currently pending just within the four federal vaginal mesh MDLs against multiple manufacturers, including C.R. Bard (MDL 2187), American Medical Systems (MDL 2325), Johnson & Johnson’s Ethicon (MDL 2327 ) and Boston Scientific (MDL 2326), which are pending in the U.S. District Court for the Southern District of West Virginia before Judge Joseph R. Goodwin, involving polypropylene mesh used to treat pelvic organ prolapse and stress urinary incontinence. “This verdict gives validity and merit to women’s transvaginal mesh claims and illustrates the gravity of some of the injuries sustained,” commented Attorney Holly Ennis of Ennis & Ennis, P.A.

Christine Scott, 53, of Bakersfield, CA had two of Bard’s mesh devices implanted in 2008 to treat occasional urinary incontinence, but has since undergone eight additional surgeries and nine other procedures due to the mesh device cutting her colon and tissue that continues to grow through the tiny holes of the mesh, according to court documents. Yet, it wasn’t until July 1, 2012 that the defendant Bard suspended sales of Scott’s mesh device in the United States. Meanwhile, in July 2011, the FDA issued a Safety Alert for all transvaginal mesh devices stating it was unclear if the “mesh is more effective than traditional non-mesh repair” and may expose patients to greater risk.

Like Ms. Scott, hundreds of women suffer as a result of transvaginal mesh devices. The FDA's Safety Alert warns that complete removal of the mesh device may not be possible and may not result in complete resolution of complications, including pain. The FD further warns that injuries include vaginal mesh erosion, pain, painful sexual intercourse (dyspareunia), infection, urinary problems, bleeding, organ perforation, recurrent prolapse, neuro-muscular problems, vaginal scarring/shrinkage and emotional problems.

If you or a loved one has suffered as a result of a transvaginal mesh device implanted in 2002 or after, you may be entitled to compensation. Contact the lawyers of Ennis & Ennis, P.A. today for a free confidential consultation by calling toll free 1-800-856-6405 or by going to http://www.ennislaw.com and completing an online case evaluation.

Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies, as well as medical device makers.

Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.

Ennis & Ennis, P.A. is also investigating cases involving Actos, Fosamax, Plavix, Pradaxa, Paxil/Birth Defect, Zoloft/Birth Defect, Prozac/Birth Defect, Depuy Hip Recall, Wright Conserve Hip Devices, Wright Profemur Hip Devices, Zimmer Hip Recall, all Metal-on-Metal Hips, Medtronic Infuse Bone Graft, Depakote, Reglan, SJS/Dilantin, and Yaz, Yasmin, Ocella Birth Control Pills.

Remember the law limits the time in which you can file a claim, so don't wait to explore your legal rights. Call today toll free 1-800-856-6405 or visit http://www.ennislaw.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Attorney David Ennis
Visit website